Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
Globus Medical (NYSE: GMED) announced its participation in the 2025 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting in San Diego from March 10-14, 2025. The company will showcase its comprehensive product portfolio at booth #2517, highlighting their latest innovation, the ExcelsiusFlex™ surgical robotic navigation system for Total Knee Arthroplasty (TKA).
The ExcelsiusFlex™ system combines accuracy, procedural flexibility, and surgeon-centric design, allowing customization of workflow. The company will also feature the PRECICE™ Intramedullary Limb Lengthening Portfolio, DuraPro™ Oscillating System, and Harvest™ SmartPrep™ 3 autologous biologic centrifuge platform.
Globus Medical will host a reception on March 12, 2025, from 5:30pm to 8:30pm at the San Diego Wine & Culinary Center, and a booth tour for analysts and investors from 1:00pm to 1:45pm the same day.
Globus Medical (NYSE: GMED) ha annunciato la sua partecipazione al Meeting Annuale dell'Accademia Americana dei Chirurghi Ortopedici (AAOS) che si terrà a San Diego dal 10 al 14 marzo 2025. L'azienda presenterà il suo ampio portafoglio di prodotti presso lo stand n. 2517, evidenziando la sua ultima innovazione, il sistema di navigazione robotica chirurgica ExcelsiusFlex™ per l'Artroplastica Totale del Ginocchio (TKA).
Il sistema ExcelsiusFlex™ combina precisione, flessibilità procedurale e un design centrato sul chirurgo, consentendo la personalizzazione del flusso di lavoro. L'azienda presenterà anche il portafoglio di allungamento degli arti intramedullari PRECICE™, il sistema oscillante DuraPro™ e la piattaforma di centrifuga biologica autologa Harvest™ SmartPrep™ 3.
Globus Medical ospiterà una reception il 12 marzo 2025, dalle 17:30 alle 20:30, presso il San Diego Wine & Culinary Center, e un tour dello stand per analisti e investitori dalle 13:00 alle 13:45 lo stesso giorno.
Globus Medical (NYSE: GMED) anunció su participación en la Reunión Anual de la Academia Americana de Cirujanos Ortopédicos (AAOS) que se llevará a cabo en San Diego del 10 al 14 de marzo de 2025. La compañía exhibirá su completo portafolio de productos en el stand #2517, destacando su última innovación, el sistema de navegación robótica quirúrgica ExcelsiusFlex™ para la Artroplastia Total de Rodilla (TKA).
El sistema ExcelsiusFlex™ combina precisión, flexibilidad en los procedimientos y un diseño centrado en el cirujano, permitiendo la personalización del flujo de trabajo. La empresa también presentará el portafolio de alargamiento de extremidades intramedulares PRECICE™, el sistema oscilante DuraPro™ y la plataforma de centrifugación biológica autóloga Harvest™ SmartPrep™ 3.
Globus Medical organizará una recepción el 12 de marzo de 2025, de 5:30 p.m. a 8:30 p.m. en el San Diego Wine & Culinary Center, y un recorrido por el stand para analistas e inversores de 1:00 p.m. a 1:45 p.m. el mismo día.
글로부스 메디컬 (NYSE: GMED)은 2025년 3월 10일부터 14일까지 샌디에이고에서 열리는 미국 정형외과 의사 학회(AAOS) 연례 회의에 참여한다고 발표했습니다. 회사는 부스 #2517에서 최신 혁신인 ExcelsiusFlex™ 수술 로봇 내비게이션 시스템을 포함한 포괄적인 제품 포트폴리오를 선보일 예정입니다. 이 시스템은 무릎 전치환술(TKA)을 위한 것입니다.
ExcelsiusFlex™ 시스템은 정확성, 절차적 유연성 및 외과의사 중심의 디자인을 결합하여 작업 흐름의 맞춤화를 가능하게 합니다. 회사는 또한 PRECICE™ 골수 내 팔다리 길이 연장 포트폴리오, DuraPro™ 진동 시스템 및 Harvest™ SmartPrep™ 3 자가 생물학적 원심분리기 플랫폼을 소개할 것입니다.
글로부스 메디컬은 2025년 3월 12일 오후 5시 30분부터 8시 30분까지 샌디에이고 와인 & 요리 센터에서 리셉션을 개최하며, 같은 날 오후 1시부터 1시 45분까지 분석가 및 투자자를 위한 부스 투어를 진행할 예정입니다.
Globus Medical (NYSE: GMED) a annoncé sa participation à la Réunion Annuelle de l'Académie Américaine des Chirurgiens Orthopédiques (AAOS) qui se déroulera à San Diego du 10 au 14 mars 2025. L'entreprise présentera son portefeuille de produits complet au stand n° 2517, mettant en avant sa dernière innovation, le système de navigation chirurgicale robotique ExcelsiusFlex™ pour l'arthroplastie totale du genou (TKA).
Le système ExcelsiusFlex™ combine précision, flexibilité procédurale et design centré sur le chirurgien, permettant la personnalisation du flux de travail. L'entreprise mettra également en avant le portefeuille d'allongement intramédullaire des membres PRECICE™, le système oscillant DuraPro™ et la plateforme de centrifugeuse biologique autologue Harvest™ SmartPrep™ 3.
Globus Medical organisera une réception le 12 mars 2025, de 17h30 à 20h30, au San Diego Wine & Culinary Center, ainsi qu'une visite du stand pour les analystes et les investisseurs de 13h00 à 13h45 le même jour.
Globus Medical (NYSE: GMED) gab seine Teilnahme an der Jahrestagung der American Academy of Orthopedic Surgeons (AAOS) bekannt, die vom 10. bis 14. März 2025 in San Diego stattfindet. Das Unternehmen wird sein umfassendes Produktportfolio am Stand #2517 präsentieren und dabei seine neueste Innovation, das ExcelsiusFlex™ chirurgische Roboter-Navigationssystem für die totale Kniearthroplastik (TKA), hervorheben.
Das ExcelsiusFlex™-System vereint Genauigkeit, Verfahrensflexibilität und ein chirurgenspezifisches Design, das die Anpassung des Arbeitsablaufs ermöglicht. Das Unternehmen wird auch das PRECICE™ intramedulläre Gliedmaßenverlängerungsportfolio, das DuraPro™ Oszillationssystem und die Harvest™ SmartPrep™ 3 autologe biologische Zentrifugenplattform vorstellen.
Globus Medical veranstaltet am 12. März 2025 von 17:30 bis 20:30 Uhr eine Empfang im San Diego Wine & Culinary Center und eine Standtour für Analysten und Investoren von 13:00 bis 13:45 Uhr am selben Tag.
- Launch of new ExcelsiusFlex™ robotic navigation system for TKA
- Expansion into Total Knee Arthroplasty market
- Comprehensive product portfolio across multiple segments
- None.
AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) in San Diego, Calif., from March 10-14, 2025.
Join Globus at booth #2517 to learn about the comprehensive Globus Medical product portfolio across Spine, Trauma, and Joint Reconstruction procedures; Enabling Technology; Power Tools; and Regenerative Biomaterials segments.
Globus will be featuring one of its latest technology innovations, the ExcelsiusFlex™ surgical robotic navigation system for Total Knee Arthroplasty (TKA), alongside its Total Joints Arthroplasty implant portfolio*. Engineered to outperform, ExcelsiusFlex™ with TKA Application consolidates accuracy, procedural flexibility, and surgeon-centric design while allowing customization of workflow for surgeon preferences, imaging modalities, and patient needs.
Globus will also feature the PRECICE™ Intramedullary Limb Lengthening Portfolio, our Power Tools Portfolio including the DuraPro™ Oscillating System, and the Harvest™ SmartPrep™ 3 autologous biologic centrifuge platform.
Globus welcomes AAOS attendees to attend a reception to meet members of the Globus Medical team and learn more about our technology offerings.
Wednesday, March 12, 2025 – 5:30pm – 8:30pm
Globus Medical Reception
San Diego Wine & Culinary Center
200 Harbor Drive, San Diego, CA
Globus Medical will also be hosting a booth tour for analysts and investors to see our latest innovative technologies and solutions in person at the conference.
Wednesday, March 12, 2025 – 1:00pm – 1:45pm
Globus Medical Investor Relations Booth Tour
AAOS Conference Floor, Booth #2517
"AAOS provides us with the unique opportunity to showcase our comprehensive portfolio of musculoskeletal procedures and enabling technology," said John Mulcahy, Chief Commercial Officer at Globus Medical. "We look forward to connecting with our surgeon partners and showcasing our latest procedural innovations including the next generation in robotics for TKA applications."
Learn more about our events at AAOS: https://www.globusmedical.com/events/conferences/aaos-2025/
Learn more about our Globus Medical Product Portfolio: https://www.globusmedical.com/musculoskeletal-solutions/
*ExcelsiusFlex is indicated for use with the GENflex2™ and ACTIFY™ Total Knee Systems.
About Globus Medical, Inc.
Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of, and the ability of Globus Medical and NuVasive to integrate, their businesses successfully and to achieve anticipated synergies, health epidemics, pandemics and similar outbreaks, including the COVID-19 pandemic, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
investors@globusmedical.com
Media contact:
Moran Chavez
media@globusmedical.com
FAQ
What new technology is Globus Medical (GMED) showcasing at AAOS 2025?
When and where is Globus Medical (GMED) hosting their investor booth tour at AAOS 2025?
What product portfolios will GMED display at AAOS 2025?
What are the key features of GMED's ExcelsiusFlex™ system for TKA?
